Using compounded GLP-1 drugs for off-label weight loss exposes providers to legal risks, including FDA and intellectual property penalties
The therapeutic effects of GLP-1 RAslowering blood glucose and promoting weight lossare driven by interactions with G protein-coupled receptors (GPCRs) located in the pancreas, central nervous system (CNS), and peripheral tisses (Figure 1)(Zheng et al., 2024)
Researchers are finding that GLP-1 agonists influence multiple pathways involved in inflammation, cardiovascular health, mood, motivation and rewardbenefits that appear to extend beyond the downstream effects of weight loss alone
For more information, contact us or book an appointment right now
Knowing the cost of Qsymia without insurance empowers residents to make better-informed choices
Carnitine, nutritional supplementation, and discontinuation of ketogenic diet therapies